Pulmonology addresses conditions affecting the lungs, airways, pleura, and respiratory muscles. The primary clinical objective of pulmonology is restoring optimal gas exchange—ensuring adequate arterial oxygen intake and efficient carbon dioxide clearance. According to the American Thoracic Society (ATS) and European Respiratory Society (ERS), structured pulmonary care reduces hospitalization risks, enhances functional exercise capacity, and slows disease progression in chronic airway and parenchymal disorders.

Pulmonology management begins with detailed clinical history taking and focused physical examination. Diagnostic evaluation includes spirometry, plethysmography, diffusing capacity of the lungs for carbon monoxide (DLCO), pulse oximetry, arterial blood gas analysis, and high-resolution computed tomography (HRCT). Advanced interventional evaluations may involve flexible bronchoscopy with bronchoalveolar lavage (BAL) or endobronchial ultrasound (EBUS). Therapeutic regimens combine individualized pharmacotherapy, oxygen therapy, non-invasive ventilation, and pulmonary rehabilitation.

• Improved Gas Exchange: Optimizes oxygen saturation and arterial carbon dioxide clearance.
• Reduced Exacerbations: Inhaled therapy protocols significantly lower the frequency of acute respiratory flare-ups (GOLD 2024).
• Enhanced Exercise Tolerance: Pulmonary rehabilitation increases six-minute walk distance and functional stamina.
• Slowing Disease Progression: Early pharmacological intervention slows lung function decline in progressive respiratory disorders.

Recovery timelines in pulmonology depend on the clinical presentation and diagnostic or therapeutic intervention performed. Outpatient non-invasive evaluations require no recovery period. Minor procedural interventions, such as diagnostic bronchoscopy, require 2 to 4 hours of post-procedure observation, with routine activities resuming within 24 hours. Chronic respiratory management involves longitudinal, lifelong care structured around quarterly or bi-annual monitoring visits.

Pulmonology addresses acute and chronic respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), pulmonary fibrosis, bronchiectasis, pulmonary hypertension, sarcoidosis, obstructive sleep apnea (OSA), and acute pulmonary infections such as pneumonia.

Patients undergoing diagnostic pulmonary testing should refrain from short-acting bronchodilators for 4 to 6 hours prior to testing as instructed by their physician. Smoking and heavy physical exertion should be avoided for 8 hours prior to diagnostic evaluations. For endoscopic procedures like bronchoscopy, strict fasting for 6 to 8 hours prior is required, and anticoagulant medications must be managed according to clinical guidelines.

Non-invasive diagnostic tests carry minimal risk, including mild, transient lightheadedness during forced expiration. Invasive diagnostic procedures like bronchoscopy carry minor risks of transient sore throat, mild hemoptysis, fever, or localized airway irritation. Rare but serious risks include pneumothorax (lung collapse), significant hemorrhage, cardiac arrhythmia, severe hypoxia, or adverse reactions to sedative medications.

The clinical pulmonary journey begins with an initial evaluation comprising spirometry, fractional exhaled nitric oxide (FeNO) measurement, or diagnostic imaging. Once a diagnosis is established, physicians initiate target pharmacological therapies—such as inhaled corticosteroids or bronchodilators—alongside non-pharmacological interventions like pulmonary rehabilitation. Follow-up care involves serial lung function testing, symptom tracking, and medication adjustments during routine clinical visits.